|
CONTROVERSIAL TOPICS
Controversy Topic 3:
The role of surgery and chemoradiotherapy
in esophageal cancer
Should
resectable esophageal cancer be
resected?
Christophe Mariette, MD, PhD
The role of
chemoradiotherapy in esophageal
cancer
Bruce D. Minsky, MD
Discussion
based on cases
David Cunningham, MD, FRCP; Bruce
D. Minsky, MD; Andrzej Szawlowski,
MD, FACS; Christophe Mariette, MD,
PhD
Controversy Topic 4:
Which neoadjuvant or adjuvant treatment
is appropriate for gastric cancer?
Surgery
Cornelis J.H. van de Velde, MD,
PhD
Preoperative
treatment
David Cunningham, MD, FRCP
Postoperative
treatment
Carsten Bokemeyer, MD
Controversy Topic 5:
Multimodality approach of liver metastases
Ablation techniques for liver metastases
Theo J.M. Ruers, MD
Combined
modality treatment of liver metastases
of colorectal cancer: Does it improve
the results of surgery?
Thomas Grünberger, MD
Discussion
based on cases
Thomas Grünberger, MD; Claus-Henning
Koehne, MD; Istvan Lang, MD, PhD;
Bernard Nordlinger, MD
Controversy Topic 6:
The optimal approach for the management
of rectal cancer
Adequate
surgical resection for rectal cancer:
The pathologist’s view
Phil Quirke, PhD, MRC Path
Adequate
surgical resection for rectal cancer:
The surgeon’s view
Bernard Nordlinger, MD
What
can be expected from preoperative
chemoradiotherapy and radiotherapy?
Hans-Joachim Schmoll, MD, PhD
Discussion
based on cases
Bengt Glimelius, MD; Bruce D. Minsky,
MD; Bernard Nordlinger, MD; Hans-
Joachim Schmoll, MD, PhD; Vincenzo
Valentini, MD
|
